views

Bermele – what’s the ‘pleasing’ “progress to date” then?

Bermele (BERM), “a company formed to acquire a target company (or companies) with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, is pleased to update shareholders on its progress to date”. The market is also apparently pleased – the shares currently 40% higher to 1.75p…